Bank of America’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
ACM
PA
CM
VCM
CA
CFM
ACI
ST
Bank of America's NAUT Position: Q1 2026 in Review
Bank of America increased its Nautilus Biotechnolgy (NAUT) stake by 213% in Q1 2026, buying an estimated $106K and bringing the position to 63,147 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #5251.
Bank of America first reported a position in NAUT in Q2 2021 and has held it in 20 quarters since. The position peaked at $333K in Q1 2022. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.
- Bank of America held 63,147 shares of Nautilus Biotechnolgy worth $245K as of Q1 2026.
- Bank of America bought 42,980 Nautilus Biotechnolgy shares in Q1 2026, an estimated $106K.
- Nautilus Biotechnolgy made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5251 holding.
- Bank of America first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 20 quarters since.
- Bank of America's Nautilus Biotechnolgy position peaked at $333K in Q1 2022.
- 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.